Researchers at China’s Nanjing Medical University have found a link between Parkinson’s patients’ depression and deterioration of white matter in their…
Voyager Therapeutics announced it’s recruiting participants for the company’s new Phase 1 clinical trial to test a new approach for…
Two Cleveland Clinic researchers are recipients of the first grants awarded by the National Institute of Health’s BRAIN Initiative in neuroethics,…
The U.S. Food and Drug Administration (FDA) has granted approval to Insightec to start a pivotal study of its Exablate Neuro…
Voyager Therapeutics’ new clinical data on VY-AADC01 as a maintenance therapy for advanced Parkinson’s disease shows  improvement in patients’ motor…
Researchers from the Massachusetts Institute of Technology (MIT) have found a new way to look for genes that protect against…
Genetic and molecular markers of quicker motor decline in Parkinson’s disease (PD) patients were identified in a computer modeling study…
Scientists in Singapore and Korea have discovered a brain mechanism that can trigger Parkinson’s disease symptoms, such as abnormal muscle stiffness,…
A Phase 1/2 clinical trial evaluating ITI-214 in patients with Parkinson’s disease (PD) has begun enrolling patients, Intra-Cellular Therapies announced.
Weight loss is common in Parkinson’s disease and can affect quality of life. A study has identified factors that can predict weight…
Get regular updates to your inbox.
